{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:30:19Z","timestamp":1791228619655,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015285","name":"Hebei Province Medical Science Research Key Project","doi-asserted-by":"publisher","award":["20250074"],"award-info":[{"award-number":["20250074"]}],"id":[{"id":"10.13039\/501100015285","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003878"],"award-info":[{"award-number":["82003878"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["H2024206062"],"award-info":[{"award-number":["H2024206062"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bbrc.2025.152027","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T19:18:02Z","timestamp":1747336682000},"page":"152027","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Tyrosine kinase inhibitors induce cardiotoxicity by causing Ca2+ overload through the inhibition of phosphoinositide 3-kinase activity"],"prefix":"10.1016","volume":"771","author":[{"given":"Meiling","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiling","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9332-5418","authenticated-orcid":false,"given":"Yanfang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.152027_bib1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrd3252","article-title":"Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes","volume":"10","author":"Force","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2025.152027_bib2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41392-023-01469-6","article-title":"Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management","volume":"8","author":"Shyam Sunder","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrc.2025.152027_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrclinonc.2015.213","article-title":"Kinase inhibitors and monoclonal antibodies in oncology: clinical implications","volume":"13","author":"Gharwan","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2025.152027_bib4","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3389\/fphys.2017.00651","article-title":"Mechanistic systems modeling to improve understanding and prediction of cardiotoxicity caused by targeted cancer therapeutics","volume":"8","author":"Shim","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbrc.2025.152027_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1042\/CS20200305","article-title":"Cardiotoxic effects of angiogenesis inhibitors","volume":"135","author":"Dobbin","year":"2021","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.bbrc.2025.152027_bib6","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nrc2106","article-title":"Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition","volume":"7","author":"Force","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2025.152027_bib7","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1159\/000529260","article-title":"Off-target effects of cancer therapy on development of therapy-induced arrhythmia: a review","volume":"148","author":"Leiva","year":"2023","journal-title":"Cardiology"},{"key":"10.1016\/j.bbrc.2025.152027_bib8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/415198a","article-title":"Cardiac excitation-contraction coupling","volume":"415","author":"Bers","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2025.152027_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.toxlet.2024.05.005","article-title":"Transcriptomics coupled with proteomics reveals osimertinib-induced myocardial mitochondrial dysfunction","volume":"397","author":"Yang","year":"2024","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bbrc.2025.152027_bib10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1161\/CIRCRESAHA.116.303975","article-title":"Control of cardiac repolarization by phosphoinositide 3-kinase signaling to ion channels","volume":"116","author":"Ballou","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2025.152027_bib11","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.bbrc.2020.07.047","article-title":"Syringic acid mitigates myocardial ischemia reperfusion injury by activating the PI3K\/Akt\/GSK-3\u03b2 signaling pathway","volume":"531","author":"Liu","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2025.152027_bib12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","article-title":"The PI3K pathway in human disease","volume":"170","author":"Fruman","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2025.152027_bib13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.semcancer.2021.06.019","article-title":"Attacking the PI3K\/Akt\/mTOR signaling pathway for targeted therapeutic treatment in human cancer","volume":"85","author":"Yu","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbrc.2025.152027_bib14","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1161\/CIRCULATIONAHA.109.873380","article-title":"Loss of cardiac phosphoinositide 3-kinase p110 alpha results in contractile dysfunction","volume":"120","author":"Lu","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2025.152027_bib15","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1161\/01.RES.0000223321.34482.8c","article-title":"Insulin-like growth factor-1 and PTEN deletion enhance cardiac L-type Ca2+ currents via increased PI3Kalpha\/PKB signaling","volume":"98","author":"Sun","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2025.152027_bib16","doi-asserted-by":"crossref","first-page":"H1690","DOI":"10.1152\/ajpheart.00531.2008","article-title":"Temporally controlled overexpression of cardiac-specific PI3Kalpha induces enhanced myocardial contractility--a new transgenic model","volume":"295","author":"Yano","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbrc.2025.152027_bib17","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/CIRCRESAHA.117.310183","article-title":"PI3K and calcium signaling in cardiovascular disease","volume":"121","author":"Ghigo","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2025.152027_bib18","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s00204-019-02448-z","article-title":"Upregulation of phosphoinositide 3-kinase prevents sunitinib-induced cardiotoxicity in vitro and in vivo","volume":"93","author":"Li","year":"2019","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.bbrc.2025.152027_bib19","article-title":"Acute osimertinib exposure induces electrocardiac changes by synchronously inhibiting the currents of cardiac ion channels","volume":"14","author":"Li","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.152027_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113962","article-title":"Pentraxin 3 regulates tyrosine kinase inhibitor-associated cardiomyocyte contraction and mitochondrial dysfunction via ERK\/JNK signalling pathways","volume":"157","author":"Chen","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2025.152027_bib21","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/cvr\/cvz006","article-title":"Ponatinib-induced cardiotoxicity: delineating the signalling mechanisms and potential rescue strategies","volume":"115","author":"Singh","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbrc.2025.152027_bib22","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jacc.2013.08.1647","article-title":"FLT3 activation improves post-myocardial infarction remodeling involving a cytoprotective effect on cardiomyocytes","volume":"63","author":"Pfister","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbrc.2025.152027_bib23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12916-023-02838-2","article-title":"Three tyrosine kinase inhibitors cause cardiotoxicity by inducing endoplasmic reticulum stress and inflammation in cardiomyocytes","volume":"21","author":"Wang","year":"2023","journal-title":"BMC Med."},{"key":"10.1016\/j.bbrc.2025.152027_bib24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10495-023-01911-8","article-title":"The Flt3-inhibitor quizartinib augments apoptosis and promotes maladaptive remodeling after myocardial infarction in mice","volume":"29","author":"Monogiou Belik","year":"2024","journal-title":"Apoptosis"},{"key":"10.1016\/j.bbrc.2025.152027_bib25","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.yjmcc.2021.02.014","article-title":"Computational model of cardiomyocyte apoptosis identifies mechanisms of tyrosine kinase inhibitor-induced cardiotoxicity","volume":"155","author":"Grabowska","year":"2021","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbrc.2025.152027_bib26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00395-023-00977-4","article-title":"Monoamine oxidase A-dependent ROS formation modulates human cardiomyocyte differentiation through AKT and WNT activation","volume":"118","author":"Di Sante","year":"2023","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.bbrc.2025.152027_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101510","article-title":"Integrated molecular signaling involving mitochondrial dysfunction and alteration of cell metabolism induced by tyrosine kinase inhibitors in cancer","volume":"36","author":"Rodr\u00edguez-Hern\u00e1ndez","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.bbrc.2025.152027_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2024.153830","article-title":"Phosphoproteomics reveals a novel mechanism underlying the proarrhythmic effects of nilotinib, vandetanib, and mobocertinib","volume":"505","author":"Wu","year":"2024","journal-title":"Toxicology"},{"key":"10.1016\/j.bbrc.2025.152027_bib29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bbrc.2022.06.074","article-title":"PLK inhibitors identified by high content phenotypic screening promote maturation of human PSC-derived cardiomyocytes","volume":"620","author":"Feng","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2025.152027_bib30","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/CIRCRESAHA.118.311209","article-title":"Human induced pluripotent stem cell-derived cardiomyocytes as models for cardiac channelopathies: a primer for non-electrophysiologists","volume":"123","author":"Garg","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2025.152027_bib31","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCRESAHA.117.305365","article-title":"Human induced pluripotent stem cell-derived cardiomyocytes: insights into molecular, cellular, and functional phenotypes","volume":"117","author":"Karakikes","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2025.152027_bib32","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/eurheartj\/ehx811","article-title":"Cancer therapy-induced cardiomyopathy: can human induced pluripotent stem cell modelling help prevent it?","volume":"40","author":"Stack","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbrc.2025.152027_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1229960","article-title":"Evaluation of chronic drug-induced electrophysiological and cytotoxic effects using human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)","volume":"14","author":"Altrocchi","year":"2023","journal-title":"Front. Pharmacol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25007417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25007417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:36:25Z","timestamp":1787776585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25007417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":33,"alternative-id":["S0006291X25007417"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152027","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tyrosine kinase inhibitors induce cardiotoxicity by causing Ca2+ overload through the inhibition of phosphoinositide 3-kinase activity","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152027"}}